Human Microbiome Market
Human Microbiome Market Size, Share and Industry Analysis Report By Product (Probiotics, Prebiotics, Medical Foods, Diagnostic Tests, Drugs, Supplements, Symbiotics and Others); By Application (Therapeutics, Diagnostics, Nutrition, Dietics and Others); By Disease (Obesity, Diabetes, Autoimmune Disorder, Metabolic and Gastrointestinal Disorders, Cancer and Other Diseases); By Research Technology (Genomics, Proteomics and Metabolomics); By Distribution Channel (Retail Pharmacies, Online Pharmacies, Supermarkets and Hypermarket) - Forecast Year 2024 – 2031
Healthcare // Advanced Genetic Sequencing
The global human
microbiome market is foreseen to grow by 28.7%, from USD 162.84 Million in 2021
to USD 1225.71 Million in 2029. Rising industry-academia collaborations for
microbiome research, increasing focus on human microbiome therapeutics
development, human microbiome as a validated target for drug development is to drive
the market for the upcoming forecast period. However, Barriers in proving the
causal link between dysbiosis and diseases, negative clinical data will
adversely impact public perception of microbiomes remains one factor hindering
the market growth over the anticipated period.
Market Definition
What is Human microbiome?
Market Overview
The
human microbiome market search study helps to thoroughly understand the
current trend in the market competitive analysis of the players in the emerging
market. Moreover, the DRO in the Human microbiome market offers valuable
perspicuity and a current scenario for making the right decision. The research
study covers the eminent players in the market with a detailed analysis of the
company and a financial overview containing their net sales, business mix and
geographical reach It mainly focuses on the key developments of the
products/services offered by the company in recent years. Besides, we at Zettabyte
have the expertise to analyses the global Human microbiome market player's
competitive landscape helping the client comprehend their specific strategic
growth approaches.
Human
microbiome market study by "Zettabyte Analytics" offers details about
the market scope, market segmentation, technological advancement in the Human
microbiome market and highlights the optimistic, competitive landscape and
trends enduring over the years.
Major players in
the Human microbiome market include 4D Pharma Plc, Atlas Biomed, Biohm Health,
Biomx, Bione, Daytwo, Enterome, Evelo Biosciences, Inc., Ferring
Pharmaceuticals, Finch Therapeutics Group, Inc., Flightpath Biosciences, Inc.,
International Flavors & Fragrances Inc., Kaleido Biosciences, Inc., Luxia
Scientific, Metabiomics, Optibiotix Health Plc., Quantbiome, Inc. (Dba Ombre),
Second Genome Inc., Seres Therapeutics, Sun Genomics, Synlogic, Inc., Vedanta
Biosciences, Inc., Viome Life Sciences, Inc., Ysopia Bioscience.
COVID-19 Impact on Global Human
Microbiome Market
The global impact
of COVID-19 has lost millions of lives with a massive cost to the healthcare
system. Moreover, the treatment cost for patients with COVID-19 has also had a
financial impact globally. the impact of COVID-19 on the Human microbiome
market has forced the companies to change their sourcing, pricing, and
promotion strategies. the Human microbiome market players are seen focusing
more on optimizing the e-commerce networks with the rising innovations in the
digital sector, which are creating new business models for the healthcare industry
player.
Research Scope
The report
provides market value for the base year 2021 and a yearly forecast from 2022 to
2029 in revenue (USD Million/ Billion). the market for each segment is present
in North America, Europe, Asia Pacific, Latin America, Middle East &
Africa, and the regional basis for the forecast mentioned above.
Key industry
dynamics, regulatory scenarios, major material dynamics and Human microbiome
market future markets are analyzed to understand their impact on demand for the
forecast period. Growth rates have been estimated using correlation, regression
and time-series analysis.
Market Segmentation
For the purpose
of this report, the global human microbiome market segmented on the basis of product
type, disease type, application, type, and region:
Product Type Outlook:
On the basis of
product type, the market is segmented into probiotics, prebiotics, diagnostic
tests, drugs, other products.
Disease Type Outlook:
On the basis of
disease type, the market is segmented into infectious diseases, endocrine and
metabolic disorders, gastrointestinal diseases, cancer, other diseases.
Figure 1 Human microbiome Market By Disease
Type (Market Size And Forecast By Value - USD Million, 2021 & 2029)
Application Outlook:
On the basis of
application, the market is segmented into therapeutics, diagnostics.
Type Outlook:
On the basis of
type, the market is segmented into microbiome consortia transplantation (FMT),
peptide, live biotherapeutic product, others.
Regional Outlook (Revenue, USD million; 2021
& 2029)
|
Regional Outlook
(Revenue, USD million; 2018-2029) |
|
|
North America |
U.S. |
|
Canada |
|
|
Europe |
Germany |
|
U.K. |
|
|
France |
|
|
Spain |
|
|
Italy |
|
|
Rest of the Europe |
|
|
Asia Pacific |
India |
|
Japan |
|
|
China |
|
|
South Korea |
|
|
Australia |
|
|
Rest of Asia-Pacific |
|
|
Middle East & Africa |
UAE |
|
Saudi Arabia |
|
|
South Africa |
|
|
Rest of Middle East & Africa |
|
|
Latin America |
Brazil |
|
Mexico |
|
|
Argentina |
|
|
Rest of Latin America |
|
Figure 2 Human microbiome Market: Regional Dynamics
An exclusive human
microbiome market research report provides an in-depth analysis of the market
dynamics across five regions: North America, Europe, South America,
Asia-Pacific, Middle East, and Africa. Furthermore, the market has been
evaluated by utilizing diverse research methodologies and internal statistical model.
Companies Considered And Profiled In This
Market Study
The players
operating in the market have undertaken several strategies related to the
market in the period 2019-2021. some of the prominent players in the human
microbiome market include
· 4D Pharma Plc
· Atlas Biomed
· Biohm Health
· Biomx
· Bione
· Daytwo
· Enterome
· Evelo Biosciences,
Inc.
· Ferring
Pharmaceuticals
· Finch Therapeutics
Group, Inc.
· Flightpath
Biosciences, Inc.
· International
Flavors & Fragrances Inc.
· Kaleido
Biosciences, Inc.
· Luxia Scientific
· Metabiomics
· Optibiotix Health
Plc.
· Quantbiome, Inc.
(Dba Ombre)
· Second Genome Inc.
· Seres Therapeutics
· Sun Genomics
· Synlogic, Inc.
· Vedanta
Biosciences, Inc.
· Viome Life
Sciences, Inc.
· Ysopia Bioscience
Global Human microbiome Market Report Scope
|
Historical
data |
2018 - 2020 |
|
Base
year for estimation |
2021 |
|
Forecast
period |
2022 - 2029 |
|
Market
size value in 2022 |
USD XX Billion |
|
Revenue
forecast in 2029 |
USD 1225.71 Million |
|
Growth
Rate |
CAGR of 28.7%
from 2022 to 2029 |
|
Quantitative
units |
Revenue in USD Million/Billion & CAGR
from 2022 to 2029 |
|
Report
coverage |
Revenue
forecast, company share, competitive landscape, growth factors, and trends |
|
Segments
covered |
Product Type, Disease Type, Application, Type |
|
Key
companies profiled |
Enterome, Seres
Therapeutics, 4D Pharma Plc |
|
Regional
Scope |
North America, Europe, Asia Pacific, Middle
East & Africa, Latin America |
|
Country
Scope |
U.S.,
Canada, Germany, U.K., France, Italy, Spain, India, Japan, China, Australia,
South Korea, Saudi Arabia, UAE, South Africa, Brazil, Mexico, Argentina |
|
Customization
scope |
Free report customization (equivalent to up
to 8 analysts’ working days) with purchase. Addition or alteration to
country, regional & segment scope. |
Product Type Outlook (Revenue, USD Million/Billion;
2018-2029)
· Probiotics
· Prebiotics
· Diagnostic Tests
· Drugs
· Other Products
Disease Type Outlook (Revenue, USD
Million/Billion; 2018-2029)
· Infectious Diseases
· Endocrine and
Metabolic Disorders
· Gastrointestinal
Diseases
· Cancer
· Other Diseases
Application Outlook (Revenue, USD
Million/Billion; 2018-2029)
· Therapeutics
· Diagnostics
Type Outlook (Revenue, USD Million/Billion;
2018-2029)
· Microbiome
Consortia Transplantation (FMT)
· Peptide
· Live Biotherapeutic
Product
· Others
Regional Outlook (Revenue, USD Million/Billion;
2018-2029)
· North America
o U.S.
o Canada
· Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of the Europe
· Asia Pacific
o India
o Japan
o China
o South Korea
o Australia
o Rest of
Asia-Pacific
· Middle East &
Africa
o UAE
o Saudi Arabia
o South Africa
o Rest of Middle East
& Africa
· Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin
America
Reasons to Buy the Report:
· Save and reduce
time carrying out entry-level research by identifying the growth, size, leading
players and segments in the global human microbiome market
· Highlights key
business priorities in order to guide the companies to reform their business
strategies and establish themselves in the wide geography.
· The key findings
and recommendations highlight crucial progressive industry trends in the human
microbiome market, thereby allowing players to develop effective long-term
strategies in order to garner their market revenue.
· Develop/modify
business expansion plans by using substantial growth offering developed and
emerging markets.
· Scrutinize in-depth
global market trends and outlook coupled with the factors driving the market,
as well as those restraining the growth at a certain extent.
· Enhance the
decision-making process by understanding the strategies that underpin
commercial interest with respect to products, segmentation and Types.
|
Chapter
1. Introduction |
|
|
1.1. Market Definition |
|
|
1.2. Research Scope |
|
|
1.2.1. Markets Covered |
|
|
1.2.2. Years Considered for
Study |
|
|
Chapter 2. Executive
Summary |
|
|
2.1. Summary Snapshot Market Size
and Forecast, 2018-2029 |
|
|
2.2. Human Microbiome Market Share by
Product Type, 2021 vs 2029 (USD Million) |
|
|
2.3. Human Microbiome Market Share by
Disease Type, 2021 vs 2029 (USD Million) |
|
|
2.4. Human Microbiome Market Share by
Application, 2021 vs 2029 (USD Million) |
|
|
2.5. Human Microbiome Market Share by
Type, 2021 vs 2029 (USD Million) |
|
|
2.6. Human Microbiome Market Share by
Region, 2021 vs 2029 (USD Million) |
|
|
Chapter 3. Key Insights |
|
|
Chapter 4. Human
Microbiome Market Segmentation & Impact Analysis |
|
|
4.1. Human Microbiome Market Indicators
Analysis |
|
|
4.1.1. Market Drivers
Analysis |
|
|
4.1.1.1. Rising
industry-academia collaborations for microbiome research |
|
|
4.1.1.2. Increasing
focus on human microbiome therapeutics development |
|
|
4.1.1.3. Human
microbiome as a validated target for drug development |
|
|
4.1.2. Market Restraint
Analysis |
|
|
4.1.2.1. Barriers in
proving the causal link between dysbiosis and diseases |
|
|
4.1.3. Market Opportunity
Analysis |
|
|
4.1.3.1. Increasing
collaborations between public-private organizations |
|
|
4.2. Regulatory Analysis |
|
|
4.2.1. North America |
|
|
4.2.1.1. U.S. |
|
|
4.2.1.2. Canada |
|
|
4.2.2. Europe |
|
|
4.2.3. Asia Pacific |
|
|
4.2.3.1. India |
|
|
4.2.3.2. Japan |
|
|
4.2.3.3. China |
|
|
4.3. Technological Insights |
|
|
4.4. COVID-19 Impact analysis on Human
Microbiome Market |
|
|
4.5. Porter’s Five Forces Analysis |
|
|
4.5.1. Bargaining Power of
Buyers/Consumers |
|
|
4.5.2. Bargaining Power of
Suppliers |
|
|
4.5.3. Threat of New Entrants |
|
|
4.5.4. Threat of Substitute
Products |
|
|
4.5.5. Intensity of Competitive
Rivalry |
|
|
4.6. Competitive Metric Space Analysis |
|
|
Chapter 5. Human
Microbiome Market, By Product Type (Market Size and Forecast by Value - USD
Million, 2018 - 2029) |
|
|
5.1. Human Microbiome Market, By Product
Type (Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
|
5.1.1. Probiotics |
|
|
5.1.1.1. Probiotics Market Estimates and Forecast,
2019-2029 (USD Million) |
|
|
5.1.1.2. Probiotics Market Estimates and Forecast,
By Region, 2019-2029 (USD Million) |
|
|
5.1.2. Prebiotics |
|
|
5.1.2.1. Prebiotics
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
5.1.2.2. Prebiotics
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
5.1.3. Diagnostic Tests |
|
|
5.1.3.1. Diagnostic
Tests Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
5.1.3.2. Diagnostic
Tests Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
5.1.4. Drugs |
|
|
5.1.4.1. Drugs
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
5.1.4.2. Drugs
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
5.1.5. Other Products |
|
|
5.1.5.1. Other
Products Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
5.1.5.2. Other Products
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
Chapter 6. Human
Microbiome Market, By Disease Type (Market Size and Forecast by Value - USD
Million, 2018 - 2029) |
|
|
6.1. Human Microbiome Market, By
Disease Type (Market Size and Forecast by Value - USD Million, 2021 &
2029) |
|
|
6.1.1. Infectious Diseases |
|
|
6.1.1.1. Infectious Diseases Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
|
6.1.1.2. Infectious Diseases Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.2. Endocrine and Metabolic
Disorders |
|
|
6.1.2.1. Endocrine and Metabolic Disorders Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.2.2. Endocrine and Metabolic Disorders Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.3. Gastrointestinal
Diseases |
|
|
6.1.3.1.
Gastrointestinal Diseases Market Estimates and Forecast, 2019-2029 (USD
Million) |
|
|
6.1.3.2. Gastrointestinal
Diseases Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.4. Cancer |
|
|
6.1.4.1. Cancer
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.4.2. Cancer
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
6.1.5. Other Diseases |
|
|
6.1.5.1. Other
Diseases Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
6.1.5.2. Other
Diseases Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
Chapter 7. Human
Microbiome Market, By Application (Market Size and Forecast by Value - USD
Million, 2017 - 2029) |
|
|
7.1. Human Microbiome Market, By
Application (Market Size and Forecast by Value - USD Million, 2021 &
2029) |
|
|
7.1.1. Therapeutics |
|
|
7.1.1.1. Therapeutics Market Estimates and Forecast,
2019-2029 (USD Million) |
|
|
7.1.1.2. Therapeutics Market Estimates and Forecast,
By Region, 2019-2029 (USD Million) |
|
|
7.1.2. Diagnostics |
|
|
7.1.2.1. Diagnostics Market Estimates and Forecast,
2019-2029 (USD Million) |
|
|
7.1.2.2. Diagnostics Market Estimates and Forecast,
By Region, 2019-2029 (USD Million) |
|
|
Chapter 8. Human
Microbiome Market, By Type (Market Size and Forecast by Value - USD Million,
2018 - 2028) |
|
|
8.1. Human Microbiome Market, By Type
(Market Size and Forecast by Value - USD Million, 2021 & 2028) |
|
|
8.1.1. FMT |
|
|
8.1.1.1.
FMT Market Estimates and Forecast, 2018-2028 (USD Million) |
|
|
8.1.1.2. FMT Market Estimates and Forecast, By
Region, 2018-2028 (USD Million) |
|
|
8.1.2. Peptide |
|
|
8.1.2.1. Peptide Market Estimates and Forecast,
2018-2028 (USD Million) |
|
|
8.1.2.2. Peptide Market Estimates and Forecast, By
Region, 2018-2028 (USD Million) |
|
|
8.1.3. Live Biotherapeutic
Product |
|
|
8.1.3.1. Live
Biotherapeutic Product Market Estimates and Forecast, 2018-2028 (USD Million) |
|
|
8.1.3.2. Live
Biotherapeutic Product Market Estimates and Forecast, By Region, 2018-2028
(USD Million) |
|
|
8.1.4. Others |
|
|
8.1.4.1. Others Market
Estimates and Forecast, 2018-2028 (USD Million) |
|
|
8.1.4.2. Others
Market Estimates and Forecast, By Region, 2018-2028 (USD Million) |
|
|
Chapter 9. Human
Microbiome Market, By Region (Market Size and Forecast by Value - USD
Million, 2018 - 2029) |
|
|
9.1. Human Microbiome Market, By Region
(Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
|
9.2. North America |
|
|
9.2.1. North America Human
Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.2.2. North America Human
Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
|
9.2.3. North America Human
Microbiome Market, By Application, 2018-2029 (USD Million) |
|
|
9.2.4. North America Human
Microbiome Market, By Type, 2018-2029 (USD Million) |
|
|
9.2.5. North America Human
Microbiome Market, By Country, 2018-2029 (USD Million) |
|
|
9.2.6. U.S. |
|
|
9.2.6.1. U.S.
Human Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.2.6.2. U.S.
Human Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
|
9.2.6.3. U.S.
Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
|
9.2.6.4. U.S.
Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
|
9.2.7. Canada |
|
|
9.2.7.1. Canada
Human Microbiome Market, By Product Type, 2017-2029 (USD Million) |
|
|
9.2.7.2. Canada
Human Microbiome Market, By Disease Type, 2017-2029 (USD Million) |
|
|
9.2.7.3. Canada
Human Microbiome Market, By Application, 2017-2029 (USD Million) |
|
|
9.2.7.4. Canada
Human Microbiome Market, By Type, 2017-2029 (USD Million) |
|
|
9.3. Europe |
|
|
9.3.1. Europe Human Microbiome Market,
By Product Type, 2018-2029 (USD Million) |
|
|
9.3.2. Europe Human Microbiome
Market, By Disease Type, 2018-2029 (USD Million) |
|
|
9.3.3. Europe Human Microbiome
Market, By Application, 2018-2029 (USD Million) |
|
|
9.3.4. EuropeHuman Microbiome
Market, By Type, 2018-2029 (USD Million) |
|
|
9.3.5. Europe Human Microbiome
Market, By Country, 2018-2029 (USD Million) |
|
|
9.3.6. Germany |
|
|
9.3.6.1. Germany
Human Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.3.6.2. Germany
Human Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
|
9.3.6.3. Germany
Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
|
9.3.6.4. Germany
Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
|
9.3.7. U.K. |
|
|
9.3.7.1. U.K. Human
Microbiome Market, By Product Type, 2017-2029 (USD Million) |
|
|
9.3.7.2. U.K.
Human Microbiome Market, By Disease Type, 2017-2029 (USD Million) |
|
|
9.3.7.3. U.K.
Human Microbiome Market, By Application, 2017-2029 (USD Million) |
|
|
9.3.7.4. U.K.
Human Microbiome Market, By Type, 2017-2029 (USD Million) |
|
|
9.3.8. France |
|
|
9.3.8.1. France
Human Microbiome Market, By Product Type, 2019-2029 (USD Million) |
|
|
9.3.8.2. France
Human Microbiome Market, By Disease Type, 2019-2029 (USD Million) |
|
|
9.3.8.3. France Human
Microbiome Market, By Application, 2019-2029 (USD Million) |
|
|
9.3.8.4. France
Human Microbiome Market, By Type, 2019-2029 (USD Million) |
|
|
9.3.9. Spain |
|
|
9.3.9.1. Spain
Human Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.3.9.2. Spain
Human Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
|
9.3.9.3. Spain
Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
|
9.3.9.4. Spain
Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
|
9.3.10. Italy |
|
|
9.3.10.1. Italy Human
Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.3.10.2. Italy
Human Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
|
9.3.10.3. Italy
Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
|
9.3.10.4. Italy
Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
|
9.3.11. Rest of Europe |
|
|
9.3.11.1. Rest of
Europe Human Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.3.11.2. Rest of
Europe Human Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
|
9.3.11.3. Rest of
Europe Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
|
9.3.11.4. Rest of
Europe Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
|
9.4. Asia Pacific |
|
|
9.4.1. Asia Pacific Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.4.2. Asia Pacific Human
Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
|
9.4.3. Asia Pacific Human
Microbiome Market, By Application, 2018-2029 (USD Million) |
|
|
9.4.4. Asia Pacific Human
Microbiome Market, By Type, 2018-2029 (USD Million) |
|
|
9.4.5. Asia Pacific Human
Microbiome Market, By Country, 2018-2029 (USD Million) |
|
|
9.4.6. India |
|
|
9.4.6.1. India Human Microbiome Market, By
Product Type, 2018-2029 (USD Million) |
|
|
9.4.6.2. India Human
Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
|
9.4.6.3. India
Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
|
9.4.6.4. India
Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
|
9.4.7. Japan |
|
|
9.4.7.1. Japan
Human Microbiome Market, By Product Type, 2017-2029 (USD Million) |
|
|
9.4.7.2. Japan
Human Microbiome Market, By Disease Type, 2017-2029 (USD Million) |
|
|
9.4.7.3. Japan
Human Microbiome Market, By Application, 2017-2029 (USD Million) |
|
|
9.4.7.4. Japan
Human Microbiome Market, By Type, 2017-2029 (USD Million) |
|
|
9.4.8. China |
|
|
9.4.8.1. China
Human Microbiome Market, By Product Type, 2019-2029 (USD Million) |
|
|
9.4.8.2. China
Human Microbiome Market, By Disease Type, 2019-2029 (USD Million) |
|
|
9.4.8.3. China Human Microbiome
Market, By Application, 2019-2029 (USD Million) |
|
|
9.4.8.4. China
Human Microbiome Market, By Type, 2019-2029 (USD Million) |
|
|
9.4.9. South Korea |
|
|
9.4.9.1. South Korea Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.4.9.2. South
Korea Human Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
|
9.4.9.3. South
Korea Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
|
9.4.9.4. South
Korea Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
|
9.4.10. Australia |
|
|
9.4.10.1. Australia
Human Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.4.10.2.
Australia Human Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
|
9.4.10.3.
Australia Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
|
9.4.10.4.
Australia Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
|
9.4.11. Rest of Asia Pacific |
|
|
9.4.11.1. Rest of
Asia Pacific Human Microbiome Market, By Product Type, 2018-2029 (USD
Million) |
|
|
9.4.11.2. Rest of
Asia Pacific Human Microbiome Market, By Disease Type, 2018-2029 (USD
Million) |
|
|
9.4.11.3. Rest of
Asia Pacific Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
|
9.4.11.4. Rest of
Asia Pacific Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
|
9.5. Middle East & Africa |
|
|
9.5.1. Middle East & Africa
Human Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.5.2. Middle East &
AfricaHuman Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
|
9.5.3. Middle East & Africa
Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
|
9.5.4. Middle East & Africa
Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
|
9.5.5. Middle East & Africa
Human Microbiome Market, By Country, 2018-2029 (USD Million) |
|
|
9.5.6. UAE |
|
|
9.5.6.1. UAE
Human Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.5.6.2. UAE
Human Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
|
9.5.6.3. UAE
Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
|
9.5.6.4. UAE
Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
|
9.5.7. Saudi Arabia |
|
|
9.5.7.1. Saudi
Arabia Human Microbiome Market, By Product Type, 2017-2029 (USD Million) |
|
|
9.5.7.2. Saudi
Arabia Human Microbiome Market, By Disease Type, 2017-2029 (USD Million) |
|
|
9.5.7.3. Saudi
Arabia Human Microbiome Market, By Application, 2017-2029 (USD Million) |
|
|
9.5.7.4. Saudi Arabia
Human Microbiome Market, By Type, 2017-2029 (USD Million) |
|
|
9.5.8. South Africa |
|
|
9.5.8.1. South Africa
Human Microbiome Market, By Product Type, 2019-2029 (USD Million) |
|
|
9.5.8.2. South
Africa Human Microbiome Market, By Disease Type, 2019-2029 (USD Million) |
|
|
9.5.8.3. South
Africa Human Microbiome Market, By Application, 2019-2029 (USD Million) |
|
|
9.5.8.4. South
Africa Human Microbiome Market, By Type, 2019-2029 (USD Million) |
|
|
9.5.9. Rest of Middle East
& Africa |
|
|
9.5.9.1. Rest of
Middle East & Africa Human Microbiome Market, By Product Type, 2018-2029
(USD Million) |
|
|
9.5.9.2. Rest of
Middle East & Africa Human Microbiome Market, By Disease Type, 2018-2029
(USD Million) |
|
|
9.5.9.3. Rest of
Middle East & Africa Human Microbiome Market, By Application, 2018-2029
(USD Million) |
|
|
9.5.9.4. Rest of
Middle East & Africa Human Microbiome Market, By Type, 2018-2029 (USD
Million) |
|
|
9.6. Latin America |
|
|
9.6.1. Latin America Human
Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.6.2. Latin America Human Microbiome
Market, By Disease Type, 2018-2029 (USD Million) |
|
|
9.6.3. Latin America Human
Microbiome Market, By Application, 2018-2029 (USD Million) |
|
|
9.6.4. Latin America Human Microbiome
Market, By Type, 2018-2029 (USD Million) |
|
|
9.6.5. Latin America Human
Microbiome Market, By Country, 2018-2029 (USD Million) |
|
|
9.6.6. Brazil |
|
|
9.6.6.1. Brazil
Human Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.6.6.2. Brazil
Human Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
|
9.6.6.3. Brazil
Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
|
9.6.6.4. Brazil
Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
|
9.6.7. Mexico |
|
|
9.6.7.1. Mexico
Human Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.6.7.2. Mexico Human
Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
|
9.6.7.3. Mexico
Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
|
9.6.7.4. Mexico
Human Microbiome Market, By 10A, 2018-2029 (USD Million) |
|
|
9.6.8. Argentina |
|
|
9.6.8.1.
Argentina Human Microbiome Market, By Product Type, 2019-2029 (USD Million) |
|
|
9.6.8.2. Argentina
Human Microbiome Market, By Disease Type, 2019-2029 (USD Million) |
|
|
9.6.8.3.
Argentina Human Microbiome Market, By Application, 2019-2029 (USD Million) |
|
|
9.6.8.4.
Argentina Human Microbiome Market, By Type, 2019-2029 (USD Million) |
|
|
9.6.9. Rest of Latin America |
|
|
9.6.9.1. Rest of Latin
America Human Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
|
9.6.9.2. Rest of
Latin America Human Microbiome Market, By Disease Type, 2018-2029 (USD
Million) |
|
|
9.6.9.3. Rest of
Latin America Human Microbiome Market, By Application, 2018-2029 (USD
Million) |
|
|
9.6.9.4. Rest of
Latin America Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
|
Chapter 10. Competitive Landscape |
|
|
10.1. Market Revenue Share by
Manufacturers |
|
|
10.2. Competitor’s Positioning |
|
|
10.3. Strategy Benchmarking |
|
|
10.3.1. Partnership &
Agreement |
|
|
10.3.2. New Product
Development |
|
|
10.3.3. Mergers & Acquisitions |
|
|
10.3.4. Investment &
Expansion |
|
|
10.4. Vendor Landscape |
|
|
10.4.1. Distributors |
|
|
10.4.2. North America |
|
|
10.4.3. Europe |
|
|
10.4.4. Asia Pacific |
|
|
10.4.5. Middle East & Africa |
|
|
10.4.6. Latin America |
|
|
10.5. Zettabyte Analytics Insights for
Competitive Landscape |
|
|
Chapter 11. Company
Profiles |
|
|
11.1. 4D Pharma Plc |
|
|
11.1.1. Company Overview |
|
|
11.1.2. Products Offered |
|
|
11.1.3. Financials |
|
|
11.1.4. Recent
Development |
|
|
11.2. Atlas Biomed |
|
|
11.2.1. Company Overview |
|
|
11.2.2. Products Offered |
|
|
11.2.3. Financials |
|
|
11.2.4. Recent
Development |
|
|
11.3. Biohm Health |
|
|
11.3.1. Company Overview |
|
|
11.3.2. Products Offered |
|
|
11.3.3. Financials |
|
|
11.3.4. Recent Development |
|
|
11.4. Biomx |
|
|
11.4.1. Company Overview |
|
|
11.4.2. Products Offered |
|
|
11.4.3. Financials |
|
|
11.4.4. Recent
Development |
|
|
11.5. Bione |
|
|
11.5.1. Company Overview |
|
|
11.5.2. Products Offered |
|
|
11.5.3. Financials |
|
|
11.5.4. Recent
Development |
|
|
11.6. Daytwo |
|
|
11.6.1. Company Overview |
|
|
11.6.2. Products Offered |
|
|
11.6.3. Financials |
|
|
11.6.4. Recent
Development |
|
|
11.7. Enterome |
|
|
11.7.1. Company Overview |
|
|
11.7.2. Products Offered |
|
|
11.7.3. Financials |
|
|
11.7.4. Recent Development |
|
|
11.8. Evelo Biosciences, Inc. |
|
|
11.8.1. Company Overview |
|
|
11.8.2. Products Offered |
|
|
11.8.3. Financials |
|
|
11.8.4. Recent
Development |
|
|
11.9. Ferring Pharmaceuticals |
|
|
11.9.1. Company Overview |
|
|
11.9.2. Products Offered |
|
|
11.9.3. Financials |
|
|
11.9.4. Recent
Development |
|
|
11.10. Finch Therapeutics Group, Inc. |
|
|
11.10.1. Company Overview |
|
|
11.10.2. Products Offered |
|
|
11.10.3. Financials |
|
|
11.10.4. Recent
Development |
|
|
11.11. Flightpath Biosciences, Inc. |
|
|
11.11.1. Company Overview |
|
|
11.11.2. Products Offered |
|
|
11.11.3. Financials |
|
|
11.11.4. Recent
Development |
|
|
11.12. International Flavors &
Fragrances Inc. |
|
|
11.12.1. Company Overview |
|
|
11.12.2. Products Offered |
|
|
11.12.3. Financials |
|
|
11.12.4. Recent
Development |
|
|
11.13. Kaleido Biosciences, Inc. |
|
|
11.13.1. Company Overview |
|
|
11.13.2. Products Offered |
|
|
11.13.3. Financials |
|
|
11.13.4. Recent
Development |
|
|
11.14. Luxia Scientific |
|
|
11.14.1. Company Overview |
|
|
11.14.2. Products Offered |
|
|
11.14.3. Financials |
|
|
11.14.4. Recent Development |
|
|
11.15. Metabiomics |
|
|
11.15.1. Company Overview |
|
|
11.15.2. Products Offered |
|
|
11.15.3. Financials |
|
|
11.15.4. Recent
Development |
|
|
11.16. Optibiotix Health Plc. |
|
|
11.16.1. Company Overview |
|
|
11.16.2. Products Offered |
|
|
11.16.3. Financials |
|
|
11.16.4. Recent
Development |
|
|
11.17. Quantbiome, Inc. (Dba Ombre) |
|
|
11.17.1. Company Overview |
|
|
11.17.2. Products Offered |
|
|
11.17.3. Financials |
|
|
11.17.4. Recent
Development |
|
|
11.18. Second Genome Inc. |
|
|
11.18.1. Company Overview |
|
|
11.18.2. Products Offered |
|
|
11.18.3. Financials |
|
|
11.18.4. Recent
Development |
|
|
13.19. Seres Therapeutics |
|
|
13.19.1. Company Overview |
|
|
13.19.2. Products Offered |
|
|
13.19.3. Financials |
|
|
13.19.4. Recent
Development |
|
|
13.20. Sun Genomics |
|
|
13.20.1. Company Overview |
|
|
13.20.2. Products Offered |
|
|
13.20.3. Financials |
|
|
13.20.4. Recent Development |
|
|
13.21. Synlogic, Inc. |
|
|
13.21.1. Company Overview |
|
|
13.21.2. Products Offered |
|
|
13.21.3. Financials |
|
|
13.21.4. Recent
Development |
|
|
13.22. Vedanta Biosciences, Inc. |
|
|
13.22.1. Company Overview |
|
|
13.22.2. Products Offered |
|
|
13.22.3. Financials |
|
|
13.22.4. Recent
Development |
|
|
13.23. Viome Life Sciences, Inc. |
|
|
13.23.1. Company Overview |
|
|
13.23.2. Products Offered |
|
|
13.23.3. Financials |
|
|
13.23.4. Recent
Development |
|
|
13.24. Ysopia Bioscience |
|
|
13.24.1. Company Overview |
|
|
13.24.2. Products Offered |
|
|
13.24.3. Financials |
|
|
13.24.4. Recent
Development |
|
|
Chapter 12. Research
Methodology |
|
|
12.1. Research Sources |
|
|
12.1.1. Primary |
|
|
12.1.2. Secondary |
|
|
12.12. Market Size Estimation |
|
|
Chapter 13. Appendix |
|
|
13.1. Discussion guide |
|
|
13.2. Knowledge Store:
Zettabyte Analytics Subscription Portal |
|
|
13.3. Available
Customizations |
|
|
13.4. Associated
Zettabyte Analytics Reports |
|
|
List of Tables |
|
|
Table 1 |
Human Microbiome Market,
By Product Type (Market Size and Forecast by Value - USD Million, 2021 &
2029) |
|
Table 2 |
Probiotics Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 3 |
Probiotics Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 4 |
Prebiotics Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 5 |
Prebiotics Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 6 |
Human Microbiome Market,
By Disease Type (Market Size and Forecast by Value - USD Million, 2021 &
2029) |
|
Table 7 |
Infectious Diseases
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 8 |
Infectious Diseases
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 9 |
Human Microbiome Market,
By Application (Market Size and Forecast by Value - USD Million, 2021 &
2029) |
|
Table 10 |
Therapeutics Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 11 |
Therapeutics Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 12 |
Diagnostics Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 13 |
Diagnostics Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 14 |
Market Estimates and Forecast, 2019-2029
(USD Million) |
|
Table 15 |
Market Estimates and Forecast, By Region,
2019-2029 (USD Million) |
|
Table 16 |
Human Microbiome Market,
By Type (Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
Table 17 |
FMT Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
Table 18 |
FMT Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
Table 19 |
Peptide Market Estimates
and Forecast, 2019-2029 (USD Million) |
|
Table 20 |
Peptide Market Estimates
and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 21 |
North America Human
Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
Table 22 |
North America Human
Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 23 |
North America Human
Microbiome Market, By Application, 2018-2029 (USD Million) |
|
Table 24 |
North America Human
Microbiome Market, By Type, 2018-2029 (USD Million) |
|
Table 25 |
North America Human
Microbiome Market, By Country, 2018-2029 (USD Million) |
|
Table 26 |
U.S. Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
Table 27 |
U.S. Human Microbiome
Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 28 |
U.S. Human Microbiome
Market, By Application, 2018-2029 (USD Million) |
|
Table 29 |
U.S. Human Microbiome
Market, By Type, 2018-2029 (USD Million) |
|
Table 30 |
Canada Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
Table 31 |
Canada Human Microbiome
Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 32 |
Canada Human Microbiome
Market, By Application, 2018-2029 (USD Million) |
|
Table 33 |
Canada Human Microbiome
Market, By Type, 2018-2029 (USD Million) |
|
Table 34 |
Europe Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
Table 35 |
Europe Human Microbiome
Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 36 |
Europe Human Microbiome
Market, By Application, 2018-2029 (USD Million) |
|
Table 37 |
EuropeHuman Microbiome
Market, By Type, 2018-2029 (USD Million) |
|
Table 38 |
Europe Human Microbiome
Market, By Country, 2018-2029 (USD Million) |
|
Table 39 |
Germany Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
Table 40 |
Germany Human Microbiome
Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 41 |
Germany Human Microbiome
Market, By Application, 2018-2029 (USD Million) |
|
Table 42 |
Germany Human Microbiome
Market, By Type, 2018-2029 (USD Million) |
|
Table 43 |
U.K. Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
Table 44 |
U.K. Human Microbiome
Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 45 |
U.K. Human Microbiome
Market, By Application, 2018-2029 (USD Million) |
|
Table 46 |
U.K. Human Microbiome
Market, By Type, 2018-2029 (USD Million) |
|
Table 47 |
France Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
Table 48 |
France Human Microbiome
Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 49 |
France Human Microbiome
Market, By Application, 2018-2029 (USD Million) |
|
Table 50 |
France Human Microbiome
Market, By Type, 2018-2029 (USD Million) |
|
Table 51 |
Spain Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
Table 52 |
Spain Human Microbiome
Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 53 |
Spain Human Microbiome
Market, By Application, 2018-2029 (USD Million) |
|
Table 54 |
Spain Human Microbiome
Market, By Type, 2018-2029 (USD Million) |
|
Table 55 |
Italy Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
Table 56 |
Italy Human Microbiome
Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 57 |
Italy Human Microbiome
Market, By Application, 2018-2029 (USD Million) |
|
Table 58 |
Italy Human Microbiome
Market, By Type, 2018-2029 (USD Million) |
|
Table 59 |
Rest of Europe Human
Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
Table 60 |
Rest of Europe Human
Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 61 |
Rest of Europe Human
Microbiome Market, By Application, 2018-2029 (USD Million) |
|
Table 62 |
Rest of Europe Human
Microbiome Market, By Type, 2018-2029 (USD Million) |
|
Table 63 |
Asia Pacific Human
Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
Table 64 |
Asia Pacific Human
Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 65 |
Asia Pacific Human
Microbiome Market, By Application, 2018-2029 (USD Million) |
|
Table 66 |
Asia Pacific Human
Microbiome Market, By Type, 2018-2029 (USD Million) |
|
Table 67 |
Asia Pacific Human
Microbiome Market, By Country, 2018-2029 (USD Million) |
|
Table 68 |
India Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
Table 69 |
India Human Microbiome
Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 70 |
India Human Microbiome
Market, By Application, 2018-2029 (USD Million) |
|
Table 71 |
India Human Microbiome
Market, By Type, 2018-2029 (USD Million) |
|
Table 72 |
Japan Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
Table 73 |
Japan Human Microbiome
Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 74 |
Japan Human Microbiome
Market, By Application, 2018-2029 (USD Million) |
|
Table 75 |
Japan Human Microbiome
Market, By Type, 2018-2029 (USD Million) |
|
Table 76 |
China Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
Table 77 |
China Human Microbiome
Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 78 |
China Human Microbiome
Market, By Application, 2018-2029 (USD Million) |
|
Table 79 |
China Human Microbiome
Market, By Type, 2018-2029 (USD Million) |
|
Table 80 |
South Korea Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
Table 81 |
South Korea Human
Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 82 |
South Korea Human
Microbiome Market, By Application, 2018-2029 (USD Million) |
|
Table 83 |
South Korea Human
Microbiome Market, By Type, 2018-2029 (USD Million) |
|
Table 84 |
Australia Human
Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
Table 85 |
Australia Human
Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 86 |
Australia Human
Microbiome Market, By Application, 2018-2029 (USD Million) |
|
Table 87 |
Australia Human
Microbiome Market, By Type, 2018-2029 (USD Million) |
|
Table 88 |
Rest of Asia Pacific
Human Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
Table 89 |
Rest of Asia Pacific
Human Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 90 |
Rest of Asia Pacific
Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
Table 91 |
Rest of Asia Pacific
Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
Table 92 |
Middle East & Africa
Human Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
Table 93 |
Middle East &
AfricaHuman Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 94 |
Middle East & Africa
Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
Table 95 |
Middle East & Africa
Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
Table 96 |
Middle East & Africa
Human Microbiome Market, By Country, 2018-2029 (USD Million) |
|
Table 97 |
UAE Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
Table 98 |
UAE Human Microbiome
Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 99 |
UAE Human Microbiome
Market, By Application, 2018-2029 (USD Million) |
|
Table 100 |
UAE Human Microbiome
Market, By Type, 2018-2029 (USD Million) |
|
Table 101 |
Saudi Arabia Human
Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
Table 102 |
Saudi Arabia Human
Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 103 |
Saudi Arabia Human
Microbiome Market, By Application, 2018-2029 (USD Million) |
|
Table 104 |
Saudi Arabia Human
Microbiome Market, By Type, 2018-2029 (USD Million) |
|
Table 105 |
South Africa Human
Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
Table 106 |
South Africa Human
Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 107 |
South Africa Human
Microbiome Market, By Application, 2018-2029 (USD Million) |
|
Table 108 |
South Africa Human
Microbiome Market, By Type, 2018-2029 (USD Million) |
|
Table 109 |
Rest of Middle East &
Africa Human Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
Table 110 |
Rest of Middle East &
Africa Human Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 111 |
Rest of Middle East &
Africa Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
Table 112 |
Rest of Middle East &
Africa Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
Table 113 |
Latin America Human
Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
Table 114 |
Latin America Human
Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 115 |
Latin America Human
Microbiome Market, By Application, 2018-2029 (USD Million) |
|
Table 116 |
Latin America Human
Microbiome Market, By Type, 2018-2029 (USD Million) |
|
Table 117 |
Latin America Human
Microbiome Market, By Country, 2018-2029 (USD Million) |
|
Table 118 |
Brazil Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
Table 119 |
Brazil Human Microbiome
Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 120 |
Brazil Human Microbiome
Market, By Application, 2018-2029 (USD Million) |
|
Table 121 |
Brazil Human Microbiome
Market, By Type, 2018-2029 (USD Million) |
|
Table 122 |
Mexico Human Microbiome
Market, By Product Type, 2018-2029 (USD Million) |
|
Table 123 |
Mexico Human Microbiome
Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 124 |
Mexico Human Microbiome
Market, By Application, 2018-2029 (USD Million) |
|
Table 125 |
Mexico Human Microbiome
Market, By Type, 2018-2029 (USD Million) |
|
Table 126 |
Argentina Human
Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
Table 127 |
Argentina Human
Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 128 |
Argentina Human
Microbiome Market, By Application, 2018-2029 (USD Million) |
|
Table 129 |
Argentina Human
Microbiome Market, By Type, 2018-2029 (USD Million) |
|
Table 130 |
Rest of Latin America
Human Microbiome Market, By Product Type, 2018-2029 (USD Million) |
|
Table 131 |
Rest of Latin America
Human Microbiome Market, By Disease Type, 2018-2029 (USD Million) |
|
Table 132 |
Rest of Latin America
Human Microbiome Market, By Application, 2018-2029 (USD Million) |
|
Table 133 |
Rest of Latin America
Human Microbiome Market, By Type, 2018-2029 (USD Million) |
|
Table 134 |
Product Launch &
Development in The Human Microbiome Market, 2018-2021 |
|
Table 135 |
Investment and Expansion
in The Human Microbiome Market, 2018-2021 |
|
Table 136 |
Partnership &
Collaboration in The Human Microbiome Market, 2018-2021 |
|
Table 137 |
Merger & Acquisition
in The Human Microbiome Market, 2018-2021 |
|
List of Figures |
|
|
Figure 1 |
Research Methodology |
|
Figure 2 |
Summary Snapshot Market
Size and Forecast, USD Million, 2021 & 2029 |
|
Figure 3 |
Global Human Microbiome
Market Segmentation & Impact Analysis |
|
Figure 4 |
Regulatory Analysis |
|
Figure 5 |
COVID-19 Impact analysis
on Human Microbiome Market |
|
Figure 6 |
Market Revenue Share by
Manufacturers |
|
Figure 7 |
Human Microbiome Market,
By Product Type (Market Size and Forecast by Value - USD Million, 2021 &
2029) |
|
Figure 8 |
Human Microbiome Market,
By Disease Type (Market Size and Forecast by Value - USD Million, 2021 &
2029) |
|
Figure 9 |
Human Microbiome Market,
By Application (Market Size and Forecast by Value - USD Million, 2021 &
2029) |
|
Figure 10 |
Human Microbiome Market,
By Type (Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
Figure 11 |
Human Microbiome Market,
By Region (Market Size and Forecast by Value - USD Million, 2021 & 2029) |
1.
Research Sources
We at Zettabyte Analytics have a
detailed and related research methodology focussed on estimating the market
size and forecasted value for the given market. Comprehensive research
objectives and scope were obtained through secondary research of the parent and
peer markets. The next step was to validate our research by various market
models and primary research. Both top-down and bottom-up approaches were
employed to estimate the market. In addition to all the research reports, data
triangulation is one of the procedures used to evaluate the market size of
segments and sub-segments.
Research Methodology
1.1. Secondary Research
The secondary research study involves various sources and databases used
to analyze and collect information for the market-oriented survey of a specific
market. We use multiple databases for our exhaustive secondary research, such
as Factiva, Dun & Bradstreet, Bloomberg, Research article, Annual reports,
Press Release, and SEC filings of significant companies. Apart from this, a
dedicated set of teams continuously extracts data of key industry players and
makes an extensive and unique segmentation related to the latest market
development.
1.2. Primary Research
The primary research includes gathering data from specific domain
experts through a detailed questionnaire, emails, telephonic interviews, and
web-based surveys. The primary interviewees for this study include an expert
from the demand and supply side, such as CEOs, VPs, directors, sales heads, and
marketing managers of tire 1,2, and 3 companies across the globe.
1.3. Data Triangulation
The data triangulation is very important for any market study, thus we
at Zettabyte Analytics focus on at least three sources to ensure a high level
of accuracy. The data is triangulated by studying various factors and trends
from both supply and demand side. All the reports published and stored in our
repository follows a detailed process to obtain a reliable insight for our
clients.
1.4. In-House Verification
To validate the segmentation
and verify the data collected, our market expert ensures whether our research
analyst is considering fine distinction before analyzing the market.
1.5. Reporting
In the end,
presenting our research reports complied in a different format for straightforward
valuation such as ppt, pdf, and excel data pack is done.
+1 716 953 3077
sales@zettabyteanalytics.com
109 S Warren St, Syracuse, NY 13202, United States